In last trading session, Eterna Therapeutics Inc (NASDAQ:ERNA) saw 0.42 million shares changing hands with its beta currently measuring 4.36. Company’s recent per share price level of $0.25 trading at $0.0 or 1.05% at ring of the bell on the day assigns it a market valuation of $12.85M. That closing price of ERNA’s stock is at a discount of -948.0% from its 52-week high price of $2.62 and is indicating a premium of 12.0% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.62 million shares which gives us an average trading volume of 711.35K if we extend that period to 3-months.

Eterna Therapeutics Inc (NASDAQ:ERNA) trade information

Upright in the green during last session for gaining 1.05%, in the last five days ERNA remained trading in the red while hitting it’s week-highest on Wednesday, 12/18/24 when the stock touched $0.25 price level, adding 16.67% to its value on the day. Eterna Therapeutics Inc’s shares saw a change of -86.07% in year-to-date performance and have moved -13.46% in past 5-day. Eterna Therapeutics Inc (NASDAQ:ERNA) showed a performance of -59.31% in past 30-days. Number of shares sold short was 44458.0 shares which calculate 1.07 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.06% during past 5 years.

Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders

Insiders are in possession of 336.35% of company’s total shares while institution are holding 11.00 percent of that, with stock having share float percentage of -4.65%. Investors also watch the number of corporate investors in a company very closely, which is 11.00% institutions for Eterna Therapeutics Inc that are currently holding shares of the company.